Cochrane · systematic review · CD009996

Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents

Punja, S, Shamseer, L, Hartling, L, et al. · Cochrane Database of Systematic Reviews · 2016 · Cochrane Library

SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
7
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 4 · 57.1%Low 3 · 42.9%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Comparison

Population: children or adolescents with ADHD
7 questions
OutcomeEffectEvidenceStatus / GRADE
Total ADHD symptom score ‐ parent ratings (ADHD Rating Scale, Fourth Version; Conners' Rating Scale; Conners' Global Index; Conners' Abbreviated Symptom Questionnaire)
no estimate extracted7 studies · 1247 participantsVery low
Downgraded: risk of bias, inconsistency
Total ADHD symptom score ‐ teacher ratings (ADHD Rating Scale, Fourth Version; Conners' Rating Scale; Conners' Global Index; Conners' Abbreviated Symptom Questionnaire)
no estimate extracted5 studies · 745 participantsLow
Downgraded: risk of bias
Total ADHD symptom score ‐ clinician ratings (ADHD Rating Scale, Fourth Version)
no estimate extracted3 studies · 813 participantsVery low
Downgraded: risk of bias, inconsistency
Proportion of responders (Clinical Global Impressions ‐ Improvement (CGI‐I) scale)
RR 3.36 [2.48, 4.55]9 studies · 2207 participantsVery low
Downgraded: risk of bias, inconsistency
Academic performance (Permanent Product Measure of Performance; Wechsler Intelligence Scale for Children ‐ Revised; Barnell Lot, Ltd Math Test; Wide Range Achievement Test)
SMD 0.56 [0.39, 0.73]8 studies · 826 participantsLow
Downgraded: risk of bias
Retention: proportion of participants who completed the trial
RR 1.03 [0.97, 1.1]11 studies · 2381 participantsVery low
Downgraded: risk of bias, inconsistency
Proportion of participants who experienced at least 1 adverse event
RR 1.3 [1.18, 1.44]6 studies · 1742 participantsLow
Downgraded: risk of bias